Skip to content
+1-516-222-6222
LCS@lachmanconsultants.com
Search
Location Selector

Current Location

  • - Global Website

  • - Ireland Website
  • About
    • Lachman Leadership Team
    • Lachman Board of Directors
  • Services
    • FDA-Related Services
    • Compliance
    • Regulatory Affairs
    • FDA 483 Response
    • Data Integrity
    • Mock FDA Inspections
    • Analytical Services
    • Biomonitoring Support
    • Strategic Planning
    • Due Diligence Audits
    • Quality Assurance and Controls
    • Scientific and Technical Assistance
    • Systems Evaluation
    • Facilities Design or Validation
    • System Process Validation or Qualification
    • Training
    • Remote Services From Lachman
  • Markets
    • Biologics
    • Advanced Therapies
    • Pharmaceuticals
    • Medical Devices
    • Related Industries
  • Blog
  • News
  • Contact
  • Careers
    • Career Opportunities
  • Resources
    • Lachman Learning
  • Location Selector
    • – Global Website
    • – Ireland Website

Lachman Consultant Services, Inc. / Articles by: John Darby
10
Jul

ISPE’s Biotech Conference Provides Important Insights

By John Darby    Jul 10, 2023    Biologics Biosimilars BLA Compliance NDA Regulatory Affairs

The ISPE 2023 Biotechnology Conference was held from 26 to 27 June in Dublin, Ireland. Much of the focus of the conference was Cell and Gene Therapy and Advanced Therapy Medicinal Products (ATMPs), terms used in the US and EU for a range of emerging therapies and products in various stages of development. At the […]

Read More
12
Oct

Some Highlights of the October PDA Conference

By John Darby    Oct 12, 2022    Compliance FDA Product quality Regulatory Affairs

The PDA Quality & Regulations Conference was held on October 5 and 6, 2022 in Amsterdam; it was healthily attended by a variety of multi-national pharma manufacturers as well as representatives of regulatory bodies from multiple EU countries as well as the USFDA. The agenda was very much data‑driven as presenters focused on how data […]

Read More

Subscribe to our blog

Recent Articles

  • January 14, 2026 GDUFA Negotiation Session
  • FDA Approved Modifications to iPLEDGE REMS Program for Isotretinoin Products
  • Lachman Consultants at the 11th Global Pharmaceutical Quality Summit

Contact Us:



Since 1978, Lachman Consultants’ multidisciplinary team of highly experienced FDA and industry experts has offered compliance, regulatory affairs, and technical services to clients around the world.
+1-516-222-6222
LCS@lachmanconsultants.com

 

Subscribe to our blog

Quick Links

  • Home
  • About
  • Services
  • Areas Served
  • Markets
  • Careers
  • Blog
  • Contact

Recent Posts

  • January 14 2026 GDUFA Negotiation Session - Lachman BlogJanuary 14, 2026 GDUFA Negotiation Session
    February 12, 2026
  • iPledge-Blogimage-LachmanBlogFDA Approved Modifications to iPLEDGE REMS Program…
    February 11, 2026
  • Poker Showdown Full HouseCompounding Showdown Set to Go to Court
    February 10, 2026
2026 © Lachman Consultant Services, Inc.Terms and ConditionsPrivacy Policy
  • About
    ▼
    • Lachman Leadership Team
    • Lachman Board of Directors
  • Services
    ▼
    • FDA-Related Services
    • Compliance
    • Regulatory Affairs
    • FDA 483 Response
    • Data Integrity
    • Mock FDA Inspections
    • Analytical Services
    • Biomonitoring Support
    • Strategic Planning
    • Due Diligence Audits
    • Quality Assurance and Controls
    • Scientific and Technical Assistance
    • Systems Evaluation
    • Facilities Design or Validation
    • System Process Validation or Qualification
    • Training
    • Remote Services From Lachman
  • Markets
    ▼
    • Biologics
    • Advanced Therapies
    • Pharmaceuticals
    • Medical Devices
    • Related Industries
  • Blog
  • News
  • Contact
  • Careers
    ▼
    • Career Opportunities
  • Resources
    ▼
    • Lachman Learning
  • Location Selector
    ▼
    • – Global Website
    • – Ireland Website
Manage Consent

We use cookies and similar technologies to improve site performance, personalize content, analyze traffic, and for marketing purposes. You can accept all cookies, reject non-essential cookies, or manage your preferences. You may change or withdraw your consent at any time in our Cookie Settings.

Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}